MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma

OBJECTIVE: There are no effective systemic therapies for adenoid cystic cancer (ACC) and lack of tumor lines and mouse models have hindered drug development. We aim to develop MYB-activated models for testing new therapeutic agents. MATERIALS AND METHODS: We studied new ACC patient-derived xenograft...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oral Oncol
Autors principals: Jiang, Yue, Gao, Ruli, Cao, Chunxia, Forbes, Lauren, Li, Jianping, Freeberg, Shelby, Fredenburg, Kristianna M, Justice, Jeb M., Silver, Natalie L, Wu, Lizi, Varma, Sushama, West, Robert, Licht, Jonathan D., Zajac-Kaye, Maria, Kentsis, Alex, Kaye, Frederic J.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7184536/
https://ncbi.nlm.nih.gov/pubmed/31606723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.oraloncology.2019.09.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars